Resource Library

Helpful resources to support your practice and your patients

Treatment Initiation

Treatment initiation resources

Preview of TEPEZZA treatment journey guide PDF

Treatment journey

An overview of the process for initiating TEPEZZA and how Horizon Patient Services can help

DOWNLOAD

Preview of the TEPEZZA patient enrollment form PDF

Patient Enrollment Form

Download the Patient Enrollment Form and enroll your patient in Horizon Patient Services

DOWNLOAD

Preview of the Horizon Patient Services brochure PDF

Horizon Patient Services brochure

A complete overview of the services and support available when you enroll your patient in Horizon Patient Services

DOWNLOAD
Preview of TEPEZZA infusion site of care guide PDF

Site of care guide

Helpful information to consider when selecting a site of care for your patient’s TEPEZZA infusions

DOWNLOAD

Preview of TEPEZZA home infusion brochure PDF

Home infusion brochure

Considerations for choosing home infusion administration of TEPEZZA
 

DOWNLOAD

Preview of TEPEZZA infusion order template PDF

Infusion order template

A customizable template that you can use to help you write a TEPEZZA infusion order.

DOWNLOAD

Preview of TEPEZZA infusion order template and guide PDF

Infusion order guide

A guide designed to help you write the infusion order for TEPEZZA
 

DOWNLOAD

Preview of customizable care team letter

Care team notification

A customizable letter used to notify co-managers and coordinate lab monitoring when TEPEZZA is initiated

DOWNLOAD


Payer Access

Payer access resources

Preview of medical necessity letter template

Letter of medical necessity template

A template letter for TEPEZZA that can be customized by the prescriber for the specific patient case where seeking payer access
 

DOWNLOAD

Preview of payer access guide preview PDF

Payer access guide

Interactive tool to help navigate the access process, with best practices for benefits investigation, completing a letter of medical necessity, prior authorizations, and appeals

DOWNLOAD


Billing and Coding

Billing and coding resources

Preview of TEPEZZA product fact sheet PDF

Product fact sheet

Key administrative product information such as NDC, Packaging, Storage, Handling, and Authorized Distributor list

DOWNLOAD

Preview of TEPEZZA acquisition overview PDF

Acquisition overview

Your reference to TEPEZZA specialty distributors and pharmacy, as well as a step-by-step ordering guide

DOWNLOAD

Preview of TEPEZZA coding at a glance PDF

Coding at a glance

A quick reference you can keep accessible as a guide to necessary codes for billing and reimbursement, updated to include new C-code

DOWNLOAD

Preview of TEPEZZA billing and coding guide PDF

Billing and coding guide

An in-depth, step-by-step guide to billing procedures, necessary codes, and reimbursement, updated to include new C-code

DOWNLOAD


Infusion

Infusion resources

Preview of TEPEZZA infusion guide PDF

Infusion guide

A detailed guide to infusing TEPEZZA, including complete instructions for preparation and administration

DOWNLOAD

Thumbnail of TEPEZZA administration video

Infusion administration video

A video that shows the key steps required for reconstitution, dilution and administration of TEPEZZA

WATCH VIDEO

Preview of TEPEZZA dosing calculations flashcard PDF

Dosing calculations flashcard

A table with precalculated dosing and infusion values for patients weighing 50 kg to 120 kg (110 lb to 265 lb)

DOWNLOAD

Preview of TEPEZZA infusion checklist PDF

Infusion checklist

A step-by-step checklist that you can use for guidance through each patient’s infusion

DOWNLOAD

Preview of TEPEZZA home infusion FAQs PDF

Home Infusion FAQs

Answers to common questions about selecting home infusion as a site of care for administering TEPEZZA
 

DOWNLOAD

Patient Education

Patient education resources

Preview of TEPEZZA patient education brochure PDF

TEPEZZA patient education brochure

An educational brochure for prospective patients to learn more about TEPEZZA
 
 

DOWNLOAD

Preview of TEPEZZA patient guide PDF

Getting Started on TEPEZZA

A brochure to guide your patients through the initial steps of getting started on TEPEZZA
 

DOWNLOAD

Preview of home infusion PDF

Patient home infusion brochure

A brochure that addresses patients' frequently asked questions about home infusion

DOWNLOAD


Clinical Education

Clinical education resources

Thumbnail of TEPEZZA peer-to-peer video

TEPEZZA and TED peer-to-peer educational video presentation

An in-depth presentation about TEPEZZA from Thyroid Eye Disease experts, Dr. Raymond S. Douglas and Dr. Terry J. Smith

WATCH VIDEO

INDICATION AND IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Infusion Reactions: TEPEZZA may cause infusion reactions. Infusion reactions have been reported in approximately 4% of patients treated with TEPEZZA. Reported infusion reactions have usually been mild or moderate in severity. Signs and symptoms may include transient increases in blood pressure, feeling hot, tachycardia, dyspnea, headache, and muscular pain. Infusion reactions may occur during an infusion or within 1.5 hours after an infusion. In patients who experience an infusion reaction, consideration should be given to premedicating with an antihistamine, antipyretic, or corticosteroid and/or administering all subsequent infusions at a slower infusion rate.

Preexisting Inflammatory Bowel Disease: TEPEZZA may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with IBD for flare of disease. If IBD exacerbation is suspected, consider discontinuation of TEPEZZA.

Hyperglycemia: Increased blood glucose or hyperglycemia may occur in patients treated with TEPEZZA. In clinical trials, 10% of patients (two-thirds of whom had preexisting diabetes or impaired glucose tolerance) experienced hyperglycemia. Hyperglycemic events should be managed with medications for glycemic control, if necessary. Monitor patients for elevated blood glucose and symptoms of hyperglycemia while on treatment with TEPEZZA. Patients with preexisting diabetes should be under appropriate glycemic control before receiving TEPEZZA.

Adverse Reactions

The most common adverse reactions (incidence ≥5% and greater than placebo) are muscle spasm, nausea, alopecia, diarrhea, fatigue, hyperglycemia, hearing impairment, dysgeusia, headache, and dry skin.

INDICATION

TEPEZZA is indicated for the treatment of Thyroid Eye Disease.

Please see Full Prescribing Information for more information.

INDICATION AND IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Infusion Reactions: TEPEZZA may cause infusion reactions. Infusion reactions have been reported in approximately 4% of patients treated with TEPEZZA. Reported infusion reactions have usually been mild or moderate in severity. Signs and symptoms may include transient increases in blood pressure, feeling hot, tachycardia, dyspnea, headache, and muscular pain. Infusion reactions may occur during an infusion or within 1.5 hours after an infusion. In patients who experience an infusion reaction, consideration should be given to premedicating with an antihistamine, antipyretic, or corticosteroid and/or administering all subsequent infusions at a slower infusion rate.

Preexisting Inflammatory Bowel Disease: TEPEZZA may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with IBD for flare of disease. If IBD exacerbation is suspected, consider discontinuation of TEPEZZA.

Hyperglycemia: Increased blood glucose or hyperglycemia may occur in patients treated with TEPEZZA. In clinical trials, 10% of patients (two-thirds of whom had preexisting diabetes or impaired glucose tolerance) experienced hyperglycemia. Hyperglycemic events should be managed with medications for glycemic control, if necessary. Monitor patients for elevated blood glucose and symptoms of hyperglycemia while on treatment with TEPEZZA. Patients with preexisting diabetes should be under appropriate glycemic control before receiving TEPEZZA.

Adverse Reactions

The most common adverse reactions (incidence ≥5% and greater than placebo) are muscle spasm, nausea, alopecia, diarrhea, fatigue, hyperglycemia, hearing impairment, dysgeusia, headache, and dry skin.

INDICATION

TEPEZZA is indicated for the treatment of Thyroid Eye Disease.

Please see Full Prescribing Information for more information.